The ESC Textbook of Heart Failure

Description:

The ESC Textbook of Heart Failure is the latest addition to the European Society of Cardiology (ESC) publications portfolio and is fully supported by the European Heart Failure Association. The textbook brings together internationally renowned experts in the field of heart failure to present an up-to-date understanding of all aspects of this chronic condition that worsens with time. It is estimated that the worldwide population of patients suffering from heart failure is approximately 26 million. This clinically oriented work reflects contemporary European guidelines from the ESC and the European Heart Failure Association and summarizes the latest evidence from clinical trials. Made up of eighteen different sections the textbook covers the epidemiology, etiology, prevention, pathophysiology, and clinical phenotypes of heart failure. The assessment and management of chronic, acute, and advance heart failure are all discussed in detail. As well as chapters dedicated to self-care and patient education, the multidisciplinary approach to heart failure management, and clinical trial design and interpretation. The future direction of the field is discussed throughout with separate chapters on digital health, big data, and telemedicine/remote monitoring in heart failure also included. A must read for cardiovascular healthcare specialists in Europe and across the world it should also appeal to those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, and specialist nurses too.

Table of Contents:

Section 1 Universal definition of heart failure

1.1 Universal definition of heart failure

Section 2 Epidemiology of heart failure

2.1 Epidemiology of heart failure

Section 3 Aetiology of heart failure

3.1 The role of ischaemic heart disease in heart failure

3.2 From hypertension to heart failure

3.3 Heart failure in valvular heart disease

3.4 Cardiomyopathies

3.4.1 Genetic basis of cardiomyopathies

3.4.2 Dilated and hypokinetic non-dilated cardiomyopathy

3.4.3 Hypertrophic cardiomyopathy

3.4.4 Restrictive cardiomyopathy

3.4.5 Arrhythmogenic right ventricular cardiomyopathy

3.4.6 Peripartum cardiomyopathy

3.4.7 Takotsubo syndrome

3.5 Myocarditis and pericarditis

3.6 Congenital heart disease

3.7 Endocrine and metabolic abnormalities

3.8 Obesity

3.9 Cancer and cancer therapy

3.10 Toxins and infections

Section 4 Prevention of heart failure

4.1 Prevention of heart failure

Section 5 Pathophysiology of heart failure

5.1 Molecular and cellular mechanisms

5.2 Alterations in myocardial metabolism

5.3 Ventricular remodelling

5.4 Neurohormonal activation in heart failure

5.5 Immune-mediated mechanisms

5.6 Inflammation, oxidative stress, and endothelial dysfunction

5.7 Alterations in renal haemodynamics and function in heart failure

5.8 Systemic adaptations in metabolism and nutritional status

Section 6 Clinical phenotypes of chronic heart failure

6.1 Clinical phenotypes of heart failure with reduced ejection fraction

6.2 Heart failure with mildly reduced ejection fraction

6.3 Heart failure with preserved ejection fraction

6.4 Right heart failure

Section 7 Chronic heart failure: diagnostic and prognostic assessment

7.1 Heart failure clinical assessment

7.2 Biomarkers in diagnostic and prognostic assessment

7.3 Imaging in heart failure

7.3.1 Echocardiography

7.3.2 Nuclear medicine

7.3.3 Computed tomography in heart failure

7.3.4 Cardiac magnetic resonance in heart failure: diagnostic and prognostic assessment

7.3.5 Cardiopulmonary exercise testing

7.4 Cardiac catheterization, invasive imaging, and haemodynamics

Section 8 Chronic heart failure: pharmacological management

8.1 Angiotensin-converting enzyme inhibitors

8.2 Angiotensin receptor blockers in heart failure

8.3 Angiotensin II receptor–neprilysin inhibitor

8.4 Beta-blocker therapy

8.5 Mineralocorticoid receptor antagonists

8.6 Heart rate reduction with ivabradine in heart failure

8.7 Vasodilators in heart failure

8.8 Digitalis glycosides

8.9 Diuretics

8.10 Inotropes and inodilators

8.11 Sodium–glucose cotransporter 2 inhibitors

8.12 Ancillary pharmacological treatment options

8.13 New and emerging therapies in heart failure

Section 9 Chronic heart failure: non-pharmacological management

9.1 Implantable cardioverter–defibrillators

9.2 Cardiac resynchronization therapy for heart failure

9.3 Cardiac surgery (bypass surgery and remodelling surgery)

9.4 Valve interventions

9.5 Ancillary procedures

9.6 Cardiovascular rehabilitation and lifestyle modifications

Section 10 Acute heart failure

10.1 Acute heart failure: diagnostic and prognostic assessment

10.2 Acute heart failure: pharmacological and non-pharmacological management

Section 11 Advanced heart failure

11.1 Advanced heart failure: assessment

11.2 Advanced heart failure: management

11.3 Mechanical circulatory support

11.4 Heart transplantation

11.5 Palliative care in the heart failure trajectory

Section 12 Comorbidities and clinical conditions

12.1 Clinical aspects of chronic kidney disease in heart failure

12.2 Dyskalaemia in heart failure

12.3 Chronic lung disease

12.4 Ventilatory abnormalities and sleep disordered breathing

12.5 Pulmonary hypertension associated with left heart disease

12.6 Ventricular arrhythmias and sudden death in heart failure

12.7 Management of atrial fibrillation in heart failure

12.8 Diabetes, prediabetes, and heart failure

12.9 Heart failure in systemic immune-mediated diseases

12.10 Liver and gut dysfunction

12.11 Iron deficiency in heart failure

12.12 Cognitive impairment and depression

12.13 Cancer and heart failure

12.14 Pregnancy and heart failure

12.15 Frailty in heart failure

Section 13 Self-care and patient education

13.1 Self-care and patient education

Section 14 Multidisciplinary approach to heart failure management

14.1 Multidisciplinary approach to heart failure management

Section 15 Clinical trial design and interpretation

15.1 Clinical trial design and interpretation

Section 16 Digital health in heart failure

16.1 Digital health in heart failure

Section 17 Big data in heart failure

17.1 Big data in heart failure

Section 18 Telemedicine and remote monitoring

18.1 Telemedicine and remote monitoring in heart failure

Index

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y